Ledning och VD

This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.

Patrik Byhmer

Patrik Byhmer

CEO and founder

Previous positions: Has extensive experience leading global businesses, managing staff, distribution networks, agents and production outside Europe. Has worked in marketing at Procter & Gamble, has been BU director for medical technology companies with global distribution (Etac AB), has set up new technology business operations in mobile technology (global V.P. Sales & Marketing gigaAnt, Perlos (present Lite-On), AnteNova).

Current position: CEO of Redsense Medical AB and Redsense Medical Inc.

Shareholding: Owns privately and via companies 1 720 414 shares and 72 463 stock options

Brendan Kane

Brendan Kane

U.S. Director of Sales

Joined: January 2016

Previous positions: Has more than 25 years of renal industry experience. Has held various sales, sales management, and business development positions with National Medical Care, Fresenius Medical Care, American Renal Associates and other renal equipment and pharmaceutical manufacturers.

Current position: U.S. Director of Sales

Shareholding: 50 000 shares

Jane Hurst

Jane Hurst

U.S. Clinical Director

Joined:

Previous positions: Started as a nurse in 1980, Jane’s experience covers a wide range of medical specialties including nephrology, hemodialysis, burns and oncology. In 2002, she obtained a certification to consult nursing issues in the judiciary; providing medical-legal knowledge to prosecutors, insurance companies, businesses and governments. For 12 years, Jane has taught a national (USA) certification program for consultants in legal-medical issues and mentored other legal-medical consultants. In addition to her work with Redsense, she still consults in legal-medical matters and has clients across the United States.

Current position: U.S. Clinical Director

Shareholding: 105 000 shares

Sebastien Bollue

Sebastien Bollue

Director Commercial Operations

Joined: June 2016

Previous positions: Sebastien joined the Company in 2016, first in the role as Commercial Operations Manager and currently serving as the Director of Commercial Operations. He has solid experience developing and managing distribution relations, and his primary task at the Company is to oversee the day-to-day commercial operations and supply chain, as well as to coordinate marketing, supply and clinical evaluations.

Current Position: Director Commercial Operations

Shareholding: 50 000 shares and 72 463 stock options

Ann-Marie Eriksson

Ann-Marie Eriksson

CTO

Joined: January 2020

Previous positions: Joining the Company as new CTO in late 2019, Anne-Marie is the most recent addition to the Company’s executive management. Ann-Marie Eriksson holds a Master of Science in Electrical Engineering with specialization in signal processing and telecommunications from the Chalmers University of Technology. Her most recent position was at the Halmstad branch of Etteplan Sweden AB, Swedish subsidiary of the international engineering group Etteplan, where she has lead the team successfully as Department Manager, Area Manager and Teamleader. She has solid experience of project management and quality systems management, with particular expertise in medical devices.

Current Position: CTO of Redsense Medical AB

Shareholding: 0